AGP Picks
View all

Medasense pain data will stream into hospital EHRs through Philips Capsule

Jul. 7, 2026
By AI, Created 12:30 UTC, Jul 07, 2026, AGP -

Medasense says pain-monitoring data from its PMD-200 monitor can now be captured in hospital electronic health records through Philips Capsule Medical Device Information Platform. The integration is meant to give anesthesiologists and intensivists real-time nociception data alongside other vital signs for more personalized pain management in surgery and critical care.

Why it matters: - Objective pain-monitoring data can now sit in the same record as other patient vitals, giving clinicians a more complete view of status in surgery and critical care. - The integration is designed to support data-driven analgesia, reduce manual transcription, and improve workflow inside the EHR. - Continuous, timestamped nociception data in the EHR can also support quality improvement, retrospective research and real-world evidence generation.

What happened: - Medasense Biometrics announced that its PMD-200 patient monitor now integrates with Philips Capsule Medical Device Information Platform, or MDIP. - The integration streams the PMD-200’s NOL-Nociception Level Index data into hospital electronic health records and clinical information systems. - The PMD-200 device driver is now available through the Philips Capsule MDIP platform for deployment at customer sites. - The announcement was dated July 7, 2026.

The details: - The PMD-200 is the first and only FDA-authorized monitor that gives clinicians an objective, real-time measure of a patient's pain response under general anesthesia and sedation. - The NOL Index is an AI-driven, multi-parameter score on a 0–100 scale that continuously quantifies nociceptive state using data from a non-invasive finger probe. - Medasense says the setup gives anesthesiologists and intensivists an objective pain signal alongside hemodynamic and respiratory data they already monitor. - Philips Capsule MDIP is described as a vendor-neutral medical device integration platform installed in more than 4,300 healthcare facilities worldwide. - Philips Capsule MDIP captures streaming data from more than 1,200 unique medical device models and converts it into information for care management, surveillance and documentation. - The integration can route PMD-200 data to major EHR systems including Epic, Oracle/Cerner and MEDITECH using standard communication protocols. - NOL Index data can also feed hospital clinical surveillance and analytics platforms. - Continuous NOL data documented in the EHR can support retrospective research, quality improvement studies and real-world evidence work. - Clinicians can access the NOL Index in the same interface they already use for other monitoring data, reducing cognitive burden.

Between the lines: - Medasense is pushing nociception-guided analgesia closer to routine use by removing one of the main operational hurdles: EHR connectivity. - The integration also fits a broader hospital trend toward consolidating device data into interoperable clinical records instead of leaving information trapped on bedside monitors. - The company frames the move as a step toward making nociception monitoring a standard-of-care parameter in the operating room and ICU, but that remains an adoption goal rather than a completed market shift.

What's next: - Hospitals using Philips Capsule MDIP can deploy the PMD-200 driver at customer sites. - Medasense expects the EHR-connected workflow to support broader use of nociception-guided analgesia in operating rooms and critical care settings. - The company says the stored data may help future research and validation of analgesia protocols.

The bottom line: - Medasense is now able to push objective pain data from the PMD-200 into hospital EHRs, which could make personalized pain management easier to document, analyze and adopt.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

New Products Launch Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Products Launch Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.